Mr Pharma

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• LIST INGRE1 refused line

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• PLANT PART1 refused line

  PLANT PART

Questions about Mr Pharma

Is Mr Pharma on an FDA import alert?

Yes. As of October 25, 2026, Mr Pharma is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for lakshadi guggul tablets; FDA published the listing on February 20, 2024.

Has FDA refused shipments from Mr Pharma?

Yes. FDA refused 2 shipment lines from Mr Pharma between October 10, 2023 and May 27, 2025. The most recent, on May 27, 2025, was herbals & botanicals (not teas), n.e.c., charged as NUTRIT LBL (nutrition information missing from label).

Why did FDA refuse Mr Pharma's shipments?

The most frequent charges are NUTRIT LBL (nutrition information missing from label, 2 lines) and LIST INGRE (ingredients not listed, 1 line).

What is Mr Pharma's FEI number?

Mr Pharma's FDA Establishment Identifier (FEI) is 3025123240.

Can shipments from Mr Pharma still enter the U.S.?

Shipments of lakshadi guggul tablets from Mr Pharma can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).